Navigation Links
OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber
Date:10/8/2007

Smaller Flexible Fiber Enables More Precise Surgical Laser Procedures

CAMBRIDGE, Mass., Oct. 8 /PRNewswire/ -- OmniGuide, Inc., a company pioneering flexible CO2 laser fibers for precision surgery, announced today the launch of its LightPath(TM) fiber for use in minimally-invasive surgical procedures.

The LightPath fiber features a fine spot size down to 200 microns enabling surgeons to safely conduct more precise procedures in Laryngology, Head & Neck Surgery, Neurotology, and Skull Base Surgery. The LightPath product employs an OmniGuide's proprietary "photonic bandgap" technology exclusive to all OmniGuide fibers, and for the first time provides a spot size and energy density level comparable to "line-of-sight" CO2 laser tools being used today.

"The LightPath product allows surgeons to cut finer incisions non- invasively, increase margin precision and minimize damage to healthy tissue while maintaining the well known safety features of CO2 laser light," explains MIT Professor Yoel Fink, OmniGuide co-founder and CEO. "OmniGuide is honored to continue to deliver breakthrough technologies to the benefit of patients and surgeons."

While CO2 laser energy offers unparalleled precision and a high degree of control over penetration into soft tissue, until recently, CO2 lasers have been limited to line-of-sight procedures due to the absence of a fiber delivery system. OmniGuide's unique technology has extended the reach of this surgical tool to minimally invasive procedures in Otology, Laryngology, Head & Neck Surgery, Laparoscopy, Gynecology, Gastroenterology and Pulmonology procedures for which there is the potential to damage delicate untargeted structures. The technology has already been used in over 1,200 such surgical procedures in some 150 medical centers.

The LightPath flexible CO2 laser fiber is now available in the United States and Europe.

About OmniGuide, Inc.

OmniGuide, Inc., based in Cambridge, MA, is the worl
'/>"/>

SOURCE OmniGuide, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationwi... Yasmin birth control pills who have suffered a De...ke, Heart Attack or other related cardiac issues o...ll free at 1-800-856-6405 or go to the firm’...t an online case evaluation form. , ...
(Date:11/25/2009)...,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleading...dsoftwareandCalgaryScientificInc.,aleadingprovider...ersionofAegis(TM)Breast4DAdvancedVisualizationsoft...zero-footprintWebclientbasedmedicalimagingoffering...allowsforzero-footprintaccess-requiringnosoftwared...
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... studies on subject, researchers note , , ...been enough studies to tell whether aspirin reduce...th the blocked leg blood vessel condition called p...studies of aspirin use with peripheral arterial di...
...ear-old Alexander, it,s meant orthotics and physic... For 7-year-old Rebecca, it,s an insulin pump for ...o has cerebral palsy, it,s a wheelchair. , , All ... help pay for desperately needed medical care or e...
...e More Informed Decisions When Choosing Nutritiona...ews stories on steroid use in sports continue to e...ements and sports nutrition products for banned su...o protecting and improving public health, has laun...
...s and experts will gather in New Orleans on June 1...ealth and property damage controversy involving bu...hey also are gathering for two teleconferences dea...least 13 states and the District of Columbia have ...
... posed by other strains of influenza, CDC says , ...health officials said Tuesday that they,re seeing ...ne flu continues to spread across the country. , "... severe complications in women with this year,s no...
...sTek, the leader in innovative electronic patient ...tion for clinical trials has continued its investm...ssisTek,s ongoing development of Smart Phone and e...9 -- assisTek, the leader in innovative electroni...
Other Medicine News:Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 2Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 3Health News:UnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey 2Health News:New Online Resource for Consumers, Athletes and Coaches Concerned About Athletic Banned Substances 2Health News:Chinese Drywall Litigation Subject of Conference and Two Teleconferences 2Health News:Swine Flu May Pose Problems for Pregnant Women 2Health News:Swine Flu May Pose Problems for Pregnant Women 3Health News:Swine Flu May Pose Problems for Pregnant Women 4Health News:Swine Flu May Pose Problems for Pregnant Women 5Health News:Swine Flu May Pose Problems for Pregnant Women 6Health News:Swine Flu May Pose Problems for Pregnant Women 7Health News:Swine Flu May Pose Problems for Pregnant Women 8Health News:Swine Flu May Pose Problems for Pregnant Women 9Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 2Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 3
(Date:11/24/2009)...REMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermil...nyfileditsPlanofReorganizationandDisclosureStateme...tcyCourtfortheDistrictofDelaware.Ahearingtoconside...ledforDecember8,2009,withthehearingontheconfirmati...ncallsfortheCompanytopayallclaimsinfull.ThePlanise...
(Date:11/24/2009)...OODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- ...andDrugAdministration(FDA)hasacceptedforreviewEisa...#174;(donepezilHClextendedrelease)tabletsforthetre...snewhigherdoseformulationcontains23mgofdonepezilHC...ysystemthatallowsforgradualreleaseofthedrug.TheNDA...
(Date:11/24/2009)...LEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Tho...ce-basedmechanicalcirculatorysupporttherapiestosav...llbeparticipatinginthe21stAnnualPiperJaffrayHealth...ith,executivevicepresidentandchieffinancialofficer...m.,EasternStandardTime(5:30a.m.,PacificStandardTim...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Curemark Announces Senior Executive Promotions 5301 1Curemark Announces Senior Executive Promotions 5301 2Curemark Announces Senior Executive Promotions 5301 3Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3Potential Pieces of Autism Puzzle Revealed 59089 1Potential Pieces of Autism Puzzle Revealed 59089 2
...EY HEIGHTS, NJ – June 4, 2007 – Genta,...tion of results,from a Phase 2 clinical trial of i...injection), plus rituximab (Rituxan®;,Genentec...d or,refractory non-Hodgkin’s lymphoma (NHL)... the American Society of Clinical,Oncology (ASCO) ...
...O--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Therape...cal collaborators today,reported updated Phase 2 d...n abnormal p53, tumor responses and increased,surv... recurrent,squamous cell carcinoma of the head and...day at the annual meeting of the American,Society ...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4
LabDAQ3 Laboratory Information System
...ies to work more efficiently has never been higher...th the COBAS INTEGRA® 400 plus, innovation mea...ndling of reaction cuvettes and improved operator ...ease-of-use required for true workload consolidati...
...ng a non-contact diagnostic lens, doctors have to ...gh magnification. Now, with the Digital Wide Fiel...n have both in one lens. This lens provides the w...s paired with the higher magnification required fo...
...Anchor is a unique double loaded anchor perfect fo...y-L Lactic Acid (PLLA) and comes in two sizes: 5.0...nds for open repairs, and can easily be cut-off fo...lows insertion with minimal procedural steps and t...
Medicine Products: